These facilities epitomize the principles of the FOYA program. ISPE is proud to honor these nine teams for their exemplary projects and outstanding dedication to creating high quality medicines for people around the world.
BETHESDA, MD, USA (PRWEB) February 01, 2016
The ISPE Facility of the Year Awards (FOYA) program announced its 2016 Category Award winners: Baxter BioPharma Solutions (Operational Excellence), Ethicon, LLC (Sustainability), Genentech (Process Innovation), Janssen Vaccines AG (Project Execution), Pfizer, Inc. (Equipment Innovation), and Takara Bio, Inc. (Facility Integration). FOYA’s judging panel has also awarded Honorable Mentions to Greater Pharma Co., Ltd., University of Strathclyde, and West Pharmaceuticals.
This premier global awards program recognizes innovation and creativity in manufacturing facilities serving the regulated healthcare industry.
“These facilities epitomize the principles of the FOYA program,” said John Bournas, ISPE President and CEO. “ISPE is proud to honor these nine teams for their exemplary projects and outstanding dedication to creating high quality medicines for people around the world.”
2016 FOYA Category Award Winners
Baxter BioPharma Solutions is the winner of the Operational Excellence award for the expansion of its parenteral manufacturing plant in Halle, Germany. The facility demonstrates operational excellence principals and innovative manufacturing concepts with state-of-the-art isolator technology, combined with high flexibility for rapid changeover and broad flexibility to manufacture a wide variety of liquid formulations.
Ethicon, LLC won the Sustainability award for its facility in San Lorenzo, Puerto Rico. The site’s Sustainability efforts resulted in energy reduction of 26% (4.4 million kWh), and water reduction of 9% (1.25 million gallons), while increasing production volume by 11%, compared to 2010 consumption levels.
Genentech (a member of the Roche Group) has been named winner of the Process Innovation award for its large-scale Cell Culture Biologics Drug Substance Plant 2 (CCP2). Located in Vacaville, California, this facility revamped an existing CCP2 Facility to support new process technology, which resulted in significant savings in capital ($50M).
Janssen Vaccines AG is the recipient of the Project Execution award for its “Fast Track Refurbishment for Ebola Vaccine Production” based in Bern, Switzerland. In response to the 2014 Ebola outbreak in West Africa, Janssen committed to accelerating the development of its candidate Ebola vaccine. Through parallel activities in process development and facility design and construction, the facility was completed for engineering runs by September 2015.
Pfizer is the winner of the Equipment Innovation award for its Portable, Continuous, Miniature and Modular (PCMM) prototype unit for Oral Solid Dosage forms, which transforms raw materials into uncoated tablets in minutes. The equipment fits into a portable facility called a POD that can be shipped to any location to get medicines to patients when and where they are needed. The PCMM model increases project speed, enhances product quality, and reduces project cost and environmental footprint. PCCM truly represents a breakthrough platform for facilities of the future.
Takara Bio, Inc. has been awarded winner of the Facility Integration award for its Center for Gene and Cell Processing (CGCP) in Shiga, Japan. In order to improve operational and cost efficiency, Takara housed cell products, viral vectors and recombinant proteins all within the same facility. To eliminate risk of cross contamination, Takara incorporated well considered facility and operational containment measures, including a RABS sterilization process using dry type vaporized hydrogen peroxide (VHP), segregated air conditioning systems, and full-height partitions to close contamination pathways.
Greater Pharma Co. Ltd. received Honorable Mention for its facility in Bangkok, Thailand. Greater Pharma is the first of its kind to apply western standards to design, build and operate a pharmaceutical facility for tablets, capsules, sachets and liquids to produce pharmaceuticals for the local ASEAN market.
University of Strathclyde received Honorable Mention for its Centre for Continuous Manufacturing and Crystallisation (CMAC) in Glasgow, Scotland. The exemplary collaboration between industry, academia and government represents the future of pharmaceutical manufacturing and supply chain R&D framework. Additionally, the students working with such technology and in such a collaborative environment will be the pipeline for the Pharmaceutical professionals of the future.
West Pharmaceuticals received Honorable Mention for its facility expansion in Kinston, North Carolina. The facility was upgraded to align with industry trends and meet regulatory requirements. West has been recognized for its industry leading efforts to align primary components manufacturing process with current industry trends and standards.
Facilities of the Future
As a result of this year’s outstanding FOYA projects, ISPE will be adding a new category to the 2017 Facility of the Year Awards: Facilities of the Future. This honor will be awarded to the project that best demonstrates the application of new, innovative concepts that make the factory a leading example for the next generation of agile, flexible and effective pharmaceutical facilities.
Industry Recognition for Category Winners
The 2016 Facility of the Year Awards Category Winners will be formally recognized at the ISPE Facility of the Year Awards Banquet on June 7, 2016 in North Bethesda, Maryland. The banquet, held in conjunction with ISPE/FDA/PQRI Quality Manufacturing Conference, will feature presentations from the FOYA judging panel and other noted industry leaders.
The 2016 FOYA Overall Winner will be announced at the 2016 ISPE Annual Meeting from September 18 – 21 in Atlanta, GA.
About the Facility of the Year Awards
The Facility of the Year Awards recognize state-of-the-art projects utilizing new, innovative technologies to improve the quality of products, reduce the cost of producing high-quality medicines, and demonstrate advances in project delivery. The FOYA program provides a platform for the pharmaceutical science and manufacturing industry to showcase its accomplishments in facility design, construction, and operation, while sharing the development of new applications of technology and cutting-edge approaches. Visit: http://www.FacilityoftheYear.org for more information.
ISPE, the International Society for Pharmaceutical Engineering, is the world’s largest not-for-profit association serving its Members through leading scientific, technical and regulatory advancement throughout the pharmaceutical lifecycle. The 20,000 Members of ISPE are building solutions in the development and manufacture of safe and effective pharmaceutical and biologic medicines and medical delivery devices in more than 90 countries around the world. Founded in 1980, ISPE has headquarter offices in Bethesda, Maryland and Tampa, Florida USA. Visit: http://www.ISPE.org for more information.
For more information contact:
Senior Director, Marketing Communications, ISPE
Tel: +1-813-960-2105, ext. 404